ALHC - Alignment Healthcare LLC

ALHC - Alignment Healthcare LLC

https://www.alignmenthealth.com

Buy Momentum: Bearish

Recent News

Powered by Alpha Vantage

Are Medical Stocks Lagging Akebia Therapeutics ( AKBA ) This Year?

Zacks Commentary • 1 month, 2 weeks ago • score: 0.34

Here is how Akebia Therapeutics (AKBA) and Alignment Healthcare (ALHC) have performed compared to their sector so far this year.

Alignment Healthcare Surges Over 23% After Strong Q2 Performance - Alignment Healthcare ( NASDAQ:ALHC )

Benzinga • 1 month, 2 weeks ago • score: 0.68

Alignment Healthcare Inc. ALHC witnessed a 23.08% surge in its stock price during premarket trading on Thursday, after the company's second-quarter earnings beat market expectations.

Alignment Healthcare ( ALHC ) Q2 Earnings and Revenues Surpass Estimates

Zacks Commentary • 1 month, 2 weeks ago • score: 0.12

Alignment Healthcare (ALHC) delivered earnings and revenue surprises of +200.00% and +5.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

High Quality, Increased Member Satisfaction, Better Access to Care and Improved Outcomes Highlight Alignment Healthcare's Impact in 2024

GlobeNewswire • 1 month, 3 weeks ago • score: 0.62

New report outlines impact of company's commitment to always putting seniors first New report outlines impact of company's commitment to always putting seniors first ...

Alignment Healthcare ( ALHC ) Upgraded to Buy: Here's What You Should Know

Zacks Commentary • 2 months, 1 week ago • score: 0.36

Alignment Healthcare (ALHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Alignment Healthcare, Inc. provides a consumer-centric platform that provides personalized healthcare to seniors in the United States. The company is headquartered in Orange, California.

52W High

$21.06

52W Low

$8.65

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.18

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

1931.42

EV/Revenue (<3 favorable)

0.89

P/S (TTM) (<3 favorable)

0.94

P/B (<3 favorable)

22.28

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

4.59%

Institutions (25–75% balanced)

96.85%

Shares Outstanding

198,031,000

Float

145,341,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

3,335,894,000

Gross Profit (TTM)

404,914,000

EPS (TTM)

-0.27

Profit Margin (>10% good)

-0.02%

Operating Margin (TTM) (higher better)

0.02%

ROE (TTM) (>15% strong)

-0.39%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.49

Momentum

Bearish momentum

Value

0.6681

Previous

0.7013

Trend

Falling

Signal Cross

No cross

As of

Sep. 11, 2025